L.T. Diemel

1.0k total citations
18 papers, 870 citations indexed

About

L.T. Diemel is a scholar working on Physiology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, L.T. Diemel has authored 18 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 12 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in L.T. Diemel's work include Pain Mechanisms and Treatments (12 papers), Nerve injury and regeneration (8 papers) and Neuropeptides and Animal Physiology (6 papers). L.T. Diemel is often cited by papers focused on Pain Mechanisms and Treatments (12 papers), Nerve injury and regeneration (8 papers) and Neuropeptides and Animal Physiology (6 papers). L.T. Diemel collaborates with scholars based in United Kingdom and Denmark. L.T. Diemel's co-authors include Paul Fernyhough, David R. Tomlinson, M. L. Cuzner, Jennifer M. Pocock, Deanna L. Taylor, Wendy J. Brewster, Elizabeth Stevens, Gary B. Willars, Gareth Pryce and David Baker and has published in prestigious journals such as Diabetes, Philosophical Transactions of the Royal Society B Biological Sciences and Neuroscience.

In The Last Decade

L.T. Diemel

18 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.T. Diemel United Kingdom 13 452 437 176 175 145 18 870
Ilona Klusáková Czechia 20 543 1.2× 670 1.5× 168 1.0× 157 0.9× 164 1.1× 40 1.1k
Stefania Echeverry Canada 9 499 1.1× 759 1.7× 120 0.7× 317 1.8× 116 0.8× 9 1.0k
Xiangmin Peng United States 12 447 1.0× 302 0.7× 300 1.7× 202 1.2× 227 1.6× 18 954
Sara Ebrahimi Nasrabady Italy 11 242 0.5× 261 0.6× 245 1.4× 233 1.3× 332 2.3× 13 1.0k
Mette Richner Denmark 15 406 0.9× 340 0.8× 133 0.8× 99 0.6× 277 1.9× 26 898
Christoforos Tsantoulas United Kingdom 16 521 1.2× 708 1.6× 159 0.9× 94 0.5× 560 3.9× 19 1.3k
Julia Kuhn United States 13 368 0.8× 580 1.3× 51 0.3× 186 1.1× 242 1.7× 15 1.0k
Christophe Crochemore Italy 15 299 0.7× 148 0.3× 103 0.6× 146 0.8× 365 2.5× 16 1.1k
Yu Cui China 16 544 1.2× 762 1.7× 126 0.7× 225 1.3× 276 1.9× 24 1.2k
John Q. Trojanowski United States 8 190 0.4× 374 0.9× 182 1.0× 256 1.5× 368 2.5× 8 918

Countries citing papers authored by L.T. Diemel

Since Specialization
Citations

This map shows the geographic impact of L.T. Diemel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.T. Diemel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.T. Diemel more than expected).

Fields of papers citing papers by L.T. Diemel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.T. Diemel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.T. Diemel. The network helps show where L.T. Diemel may publish in the future.

Co-authorship network of co-authors of L.T. Diemel

This figure shows the co-authorship network connecting the top 25 collaborators of L.T. Diemel. A scholar is included among the top collaborators of L.T. Diemel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.T. Diemel. L.T. Diemel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jackson, Samuel J., Gareth Pryce, L.T. Diemel, M. L. Cuzner, & David Baker. (2005). Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. Neuroscience. 134(1). 261–268. 69 indexed citations
2.
Taylor, Deanna L., L.T. Diemel, M. L. Cuzner, & Jennifer M. Pocock. (2002). Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up‐regulated in Alzheimer's disease. Journal of Neurochemistry. 82(5). 1179–1191. 122 indexed citations
3.
Diemel, L.T., Fei Cai, Praveen Anand, et al.. (1999). Increased nerve growth factor mRNA in lateral calf skin biopsies from diabetic patients. Diabetic Medicine. 16(2). 113–119. 29 indexed citations
4.
Tandrup, Trine, et al.. (1999). The structural effect of systemic NGF treatment on permanently axotomised dorsal root ganglion cells in adult rats. Journal of Anatomy. 194(3). 373–379. 9 indexed citations
5.
Kruger, Genevieve M., et al.. (1999). Myelin basic protein isoforms in myelinating and remyelinating rat brain aggregate cultures. Journal of Neuroscience Research. 56(3). 241–247. 11 indexed citations
6.
Diemel, L.T., et al.. (1998). Macrophages in CNS Remyelination: Friend or Foe?. Neurochemical Research. 23(3). 341–347. 67 indexed citations
7.
Fernyhough, Paul, L.T. Diemel, & David R. Tomlinson. (1998). Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia. 41(3). 300–306. 87 indexed citations
8.
Fernyhough, Paul, et al.. (1997). Role of Neurotrophins in Diabetic Neuropathy and Treatment with Nerve Growth Factors. Diabetes. 46(Supplement_2). S43–S49. 156 indexed citations
9.
Tomlinson, David R., Paul Fernyhough, & L.T. Diemel. (1996). Neurotrophins and peripheral neuropathy. Philosophical Transactions of the Royal Society B Biological Sciences. 351(1338). 455–462. 67 indexed citations
10.
Tomlinson, David R., Paul Fernyhough, L.T. Diemel, & Kengo Maeda. (1996). Deficient Neurotrophic Support in the Aetiology of Diabetic Neuropathy. Diabetic Medicine. 13(7). 679–681. 17 indexed citations
11.
Milner, P., R. Crowe, Paul Fernyhough, et al.. (1995). Nerve growth factor treatment of adult rats selectively enhances innervation of urinogenital tract rather than vascular smooth muscle. International Journal of Developmental Neuroscience. 13(5). 393–401. 8 indexed citations
12.
Fernyhough, Paul, L.T. Diemel, Wendy J. Brewster, & David R. Tomlinson. (1994). Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: Effects of insulin treatment. Neuroscience. 62(2). 337–344. 84 indexed citations
13.
14.
Singh, Jyotsna, L.T. Diemel, Gary B. Willars, & David R. Tomlinson. (1993). The extraction and assay of substance P in the rat sciatic nerve. Journal of Neuroscience Methods. 47(1-2). 133–137. 2 indexed citations
15.
Tomlinson, David R., et al.. (1993). Limitations of the Polyol Hypothesis in the Pathobiology of Experimental Diabetic Neuropathy. Diabetic Medicine. 10(S2). 27S–30S. 6 indexed citations
16.
Tsigos, C., L.T. Diemel, Anne White, David R. Tomlinson, & Robert J. Young. (1993). Cerebrospinal fluid levels of substance P and calcitonin-gene-related peptide: Correlation with sural nerve levels and neuropathic signs in sensory diabetic polyneuropathy. Clinical Science. 84(3). 305–311. 28 indexed citations
17.
Diemel, L.T., Elizabeth Stevens, Gary B. Willars, & David R. Tomlinson. (1992). Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibition. Neuroscience Letters. 137(2). 253–256. 70 indexed citations
18.
Smith, W. J. Bernhard, L.T. Diemel, R.M. Leach, & David R. Tomlinson. (1991). Central hypoxaemia in rats provokes neurological defects similar to those seen in experimental diabetes mellitus: Evidence for a partial role of endoneurial hypoxia in diabetic neuropathy. Neuroscience. 45(2). 255–259. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026